NEW YORK — The New York Yankees spent months denying what had become obvious to anyone watching.
Anthony Volpe was hurt. His shoulder wasn’t right. His throws lacked their usual carry. His swing timing fell apart.
Yet general manager Brian Cashman and manager Aaron Boone kept insisting their 24-year-old shortstop was fine.
Now the truth is out. Volpe underwent surgery Tuesday to repair a torn labrum in his left shoulder, according to reports confirmed by team sources. The procedure, performed by Yankees physician Dr. Chris Ahmad, came after Volpe spent most of the 2025 season playing through pain. He hit just .212, committed 19 errors, and struck out 150 times in 596 plate appearances.
The injury dated back to May 3 against the Tampa Bay Rays, meaning the Yankees allowed their prized young shortstop to play through a significant shoulder tear for nearly five months.
Cashman kept it hidden from Yankees nation
In September, Cashman publicly downplayed the injury’s severity. “They’ll just repeat imaging at the end of the year and see where he’s at,” Cashman said at the time, as reported by Gary Phillips. “But as of right now, there’s no surgery recommended. There’s not even an IL recommendation.”
Those words now ring hollow. The Yankees reportedly gave Volpe cortisone injections in both July and September, yet continued to run him out every day. He finished the year in visible discomfort and struggled through one of the worst stretches of his career, including an 0-for-15 skid in the playoffs against Toronto.
The Yankees had an alternative ready. Jose Caballero, acquired from Tampa Bay, hit .266 and played outstanding defense, ranking among the league’s best with five outs above average in limited time. Volpe, meanwhile, posted a minus-6 mark. Still, Caballero received only one postseason start.
Cashman undermines his credibility as Yankees GM
Brian Cashman’s handling of Volpe’s injury has intensified questions about his leadership and honesty. The Yankees’ general manager, who has been with the organization for nearly three decades, told reporters there was no need for surgery and no reason to shut down the shortstop. Yet medical records show Volpe had already received multiple cortisone shots for a torn labrum.
Cashman’s insistence that everything was fine now appears as either deliberate misdirection or professional negligence. He had acquired Caballero as insurance, then refused to use him while Volpe’s performance deteriorated. The shortstop’s .663 OPS ranked among the lowest in baseball, and his defensive metrics declined sharply.
By prioritizing optics over results, Cashman chose to protect his previous roster decisions rather than the long-term health of a cornerstone player. His September statement about Volpe’s condition stood as one of the most misleading remarks of his tenure.
Volpe’s playoff nightmare exposed the Yankees’ stubbornness
The American League Division Series against Toronto exposed the consequences of that denial. Volpe went 1-for-15 with 11 strikeouts across four games. His poor at-bats and misplays in the field underscored the damage done by months of playing through pain.
By Game 4, Boone’s patience had finally worn thin. He replaced Volpe in the ninth inning with Jasson Dominguez, who promptly doubled and scored on Aaron Judge’s RBI single. That sequence was a reminder that Boone had viable options but refused to use them until it was too late.
“I’ve never really experienced something like this, but I know what I’m capable of,” Volpe said in July after committing two costly errors in a loss to Tampa Bay. “It’s frustrating but not discouraging.”
By season’s end, Volpe’s 19 errors tied for third-most in MLB. Once seen as a defensive anchor, his fielding had turned into a liability. The Yankees knew the cause — and stayed silent.
Boone let Volpe play despite injury that cost Yankees in playoffs
Aaron Boone’s decision to keep playing Volpe despite his obvious injury symptoms showed a troubling lack of accountability. Boone had a healthy Caballero available, hitting .266 and providing elite infield defense, but stayed loyal to the struggling shortstop even as he faltered in crucial moments.
Throughout the ALDS, Boone watched Volpe’s swing fall apart and his throws sail or short-hop first base. Still, he refused to make an adjustment until the series was nearly lost. When he finally pulled Volpe for Dominguez, the offense immediately responded — too late to change the outcome.
A manager’s first responsibility is to put the best lineup on the field. Boone’s loyalty to an injured player cost the Yankees valuable games, and perhaps their season.
Caballero earned his chance but never got it
The numbers made the decision to bench Caballero even more baffling. After joining New York, he slashed .266/.372/.456 with 15 stolen bases in just 95 plate appearances. His glove work and energy offered a spark the Yankees lineup sorely lacked.
Volpe, meanwhile, saw his production plummet. His .212 average and .391 slugging percentage placed him near the bottom of all qualified shortstops. His strikeout rate soared, and his contact quality declined sharply.
The Yankees acquired Caballero as an insurance policy. Yet when the time came to use that coverage, both Cashman and Boone ignored it. Caballero had one plate appearance in the entire Division Series. Loyalty outweighed logic.
Recovery timeline raises more questions for Yankees
Dr. Spencer Stein, an orthopedic surgeon at NYU Langone Health, said a labrum repair typically requires six to nine months of recovery. That timeline could delay Volpe’s return until early summer 2026, casting doubt on his availability for Opening Day.
This creates another problem for the Yankees. The upcoming shortstop market is thin, and few trade options exist. That means the Yankees may have no choice but to rely on Caballero or promote from within.
The situation has left fans frustrated and distrustful. What began as an injury mystery has turned into a public relations disaster.
The real cost of hiding Volpe’s injury
For all their denials, the Yankees ended another season short of expectations — bounced in the Division Series, with a compromised shortstop now recovering from major surgery. They had a healthy replacement ready but refused to use him.
This wasn’t about toughness. It was about image management. The Yankees wanted to preserve the appearance that their young star was fine. Instead, they risked his future and damaged their own credibility.
When a player feels a “pop” diving for a ground ball, when he requires multiple injections just to play, any responsible front office shuts him down. The Yankees did the opposite. They gambled with Volpe’s health and lost. Now, as Volpe faces months of rehabilitation, the Yankees are left with more than an injured player — they face a crisis of trust. For a franchise that once prided itself on accountability and transparency, the Volpe situation has become a case study in how poor leadership decisions can erode both.
What do you think? Leave your comment below.
Boone is at fault for never standing up for any of his injured players. He just let it go. Cashman has admitted to ignoring medical advice, and the organization doesn’t like to use rehab assignments, but like their gizmos.